Risk factors for regional lymph node metastasis in rectal neuroendocrine tumors: a population-based study

被引:0
作者
Li, Ruizhen [1 ]
Li, Xiaofen [1 ]
Wang, Yan [1 ]
Chang, Chen [1 ]
Lv, Wanrui [1 ]
Li, Xiaoying [1 ]
Cao, Dan [2 ]
机构
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Abdominal Oncol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, Abdominal Oncol Ward, Canc Ctr, State Key Lab Biotherapy,West China Hosp,Div Med O, Chengdu, Sichuan, Peoples R China
关键词
regional lymph node metastasis; rectal neuroendocrine tumors; SEER; West China hospital databases; tumor size; PROGNOSTIC-FACTORS; GUIDELINES; MANAGEMENT; NEOPLASMS; UPDATE;
D O I
10.3389/fmed.2024.1383047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The identification of risk factors for regional lymph node (r-LN) metastasis in rectal neuroendocrine tumors (R-NETs) remains challenging. Our objective was to investigate the risk factors associated with patients diagnosed with R-NETs exhibiting r-LN metastasis. Methods: Patient information was obtained from the Surveillance, Epidemiology, and End Results (SEER) database, complemented by data from the West China Hospital (WCH) databases. The construction cohort comprised patients diagnosed with R-NETs from the SEER database, while cases from the WCH database were utilized as the validation cohort. A novel nomogram was developed to predict the probability of r-LN metastasis, employing a logistic regression model. Results: Univariate analysis identified four independent risk factors associated with poor r-LN metastasis: age (HR = 1.027, p < 0.05), grade (HR = 0.010, p < 0.05), T stage (HR = 0.010, p < 0.05), and tumor size (HR = 0.005, p < 0.05). These factors were selected as predictors for nomogram construction. Discussion: The novel nomogram serves as a reliable tool for predicting the risk of r-LN metastasis, providing clinicians with valuable assistance in identifying high-risk patients and tailoring individualized treatments.
引用
收藏
页数:8
相关论文
共 25 条
  • [1] Gastrointestinal neuroendocrine tumors in 2020
    Ahmed, Monjur
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (08) : 791 - 807
  • [2] Update on gastroenteropancreatic neuroendocrine tumors
    Andreasi, Valentina
    Partelli, Stefano
    Muffatti, Francesca
    Manzoni, Marco F.
    Capurso, Gabriele
    Falconi, Massimo
    [J]. DIGESTIVE AND LIVER DISEASE, 2021, 53 (02) : 171 - 182
  • [3] Neuroendocrine neoplasms of rectum: A management update
    Bertani, Emilio
    Ravizza, Davide
    Milione, Massimo
    Massironi, Sara
    Grana, Chiara Maria
    Zerini, Dario
    Piccioli, Alessandra Nella
    Spinoglio, Giuseppe
    Fazio, Nicola
    [J]. CANCER TREATMENT REVIEWS, 2018, 66 : 45 - 55
  • [4] Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
    de Mestier, Louis
    Lepage, Come
    Baudin, Eric
    Coriat, Romain
    Courbon, Frederic
    Couvelard, Anne
    Cao, Christine Do
    Frampas, Eric
    Gaujoux, Sebastien
    Gincul, Rodica
    Goudet, Pierre
    Lombard-Bohas, Catherine
    Poncet, Gilles
    Smith, Denis
    Ruszniewski, Philippe
    Lecomte, Thierry
    Bouche, Olivier
    Walter, Thomas
    Cadiot, Guillaume
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (05) : 473 - 492
  • [5] Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance
    Gallo, Camilla
    Rossi, Roberta Elisa
    Cavalcoli, Federica
    Barbaro, Federico
    Boskoski, Ivo
    Invernizzi, Pietro
    Massironi, Sara
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (11) : 1123 - 1138
  • [6] Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract
    Goretzki, Peter E.
    Mogl, Martina T.
    Akca, Aycan
    Pratschke, Johann
    [J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2018, 19 (02) : 169 - 178
  • [7] Hiyoshi Y, 2023, ANN SURG ONCOL, V30, P3944, DOI 10.1245/s10434-023-13348-z
  • [8] ASO Author Reflections: Rectal Neuroendocrine Tumors Have Strong Potential for Lymph Node Metastasis in Accordance with an Increase of Risk Factors, and Lymph Node Metastasis is Associated with a Poor Prognosis
    Hiyoshi, Yukiharu
    Mukai, Toshiki
    Nagasaki, Toshiya
    Yamaguchi, Tomohiro
    Akiyoshi, Takashi
    Fukunaga, Yosuke
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (07) : 3954 - 3955
  • [9] Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms
    Iabichino, Giuseppe
    Di Leo, Milena
    Arena, Monica
    Passoni, Giovanni Giuseppe Rubis
    Morandi, Elisabetta
    Turpini, Francesca
    Viaggi, Paolo
    Luigiano, Carmelo
    De Luca, Luca
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (34) : 4943 - 4958
  • [10] A 35-year retrospective study of carcinoid tumors in Taiwan - Differences in distribution with a high probability of associated second primary malignancies
    Li, Anna Fen-Yau
    Hsu, Chih-Yi
    Li, Alice
    Tai, Ling-Chen
    Liang, Wen-Yih
    Li, Win-Yin
    Tsay, Shyh-Haw
    Chen, Jeou-Yuan
    [J]. CANCER, 2008, 112 (02) : 274 - 283